Predilife SA Sustainability Reports
Predilife S.A. specializes in developing artificial intelligence-driven medical software and predictive multi-pathology health risk assessments. The company primarily designs tools like MammoRisk for estimating breast cancer risks to assist in personalized medicine.
Sector: Media & publishing
Country: France
Exchange: Euronext Paris
LEI: 9695006IK5NBKHQU9116
FIGI: BBG00MTXPT79
1 reports from 2022 to 2022
